A citation-based method for searching scientific literature

C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
Times Cited: 398







List of co-cited articles
1322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Kynurenines in the mammalian brain: when physiology meets pathology.
Robert Schwarcz, John P Bruno, Paul J Muchowski, Hui-Qiu Wu. Nat Rev Neurosci 2012
733
26

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
722
24


From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
21

Quinolinic acid, the inescapable neurotoxin.
Gilles J Guillemin. FEBS J 2012
257
21

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner, Martin Walter, Tomasz Gos, Gilles J Guillemin, Hans-Gert Bernstein, Zoltán Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise Meyer zu Schwabedissen,[...]. J Neuroinflammation 2011
321
21

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
19

Kynurenine pathway in depression: A systematic review and meta-analysis.
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Yuki Omura, Masataka Wada, Ryosuke Tarumi, Eric Plitman, Sho Moriguchi,[...]. Neurosci Biobehav Rev 2018
79
24

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
17

Kynurenine pathway in major depression: evidence of impaired neuroprotection.
Aye-Mu Myint, Yong Ku Kim, Robert Verkerk, Simon Scharpé, Harry Steinbusch, Brian Leonard. J Affect Disord 2007
352
17

Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
Jonathan Savitz, Wayne C Drevets, Brent E Wurfel, Bart N Ford, Patrick S F Bellgowan, Teresa A Victor, Jerzy Bodurka, T Kent Teague, Robert Dantzer. Brain Behav Immun 2015
108
17

Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
Jonathan Savitz, Wayne C Drevets, Chelsey M Smith, Teresa A Victor, Brent E Wurfel, Patrick S F Bellgowan, Jerzy Bodurka, T Kent Teague, Robert Dantzer. Neuropsychopharmacology 2015
129
16


Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Lucile Capuron, Gabriele Neurauter, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Dietmar Fuchs, Andrew H Miller. Biol Psychiatry 2003
313
15

Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
428
15

NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.
Adam K Walker, David P Budac, Stephanie Bisulco, Anna W Lee, Robin A Smith, Brent Beenders, Keith W Kelley, Robert Dantzer. Neuropsychopharmacology 2013
241
15

Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.
S Fukui, R Schwarcz, S I Rapoport, Y Takada, Q R Smith. J Neurochem 1991
484
15

A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
Cecilie Bay-Richter, Klas R Linderholm, Chai K Lim, Martin Samuelsson, Lil Träskman-Bendz, Gilles J Guillemin, Sophie Erhardt, Lena Brundin. Brain Behav Immun 2015
161
15

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
819
14

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
M C Wichers, G H Koek, G Robaeys, R Verkerk, S Scharpé, M Maes. Mol Psychiatry 2005
315
14

The kynurenine pathway: a finger in every pie.
Jonathan Savitz. Mol Psychiatry 2020
90
15

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
13

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
423
13

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
13

Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
J M Parrott, L Redus, D Santana-Coelho, J Morales, X Gao, J C O'Connor. Transl Psychiatry 2016
68
19


Serum kynurenic acid is reduced in affective psychosis.
B E Wurfel, W C Drevets, S A Bliss, J R McMillin, H Suzuki, B N Ford, H M Morris, T K Teague, R Dantzer, J B Savitz. Transl Psychiatry 2017
39
33

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
396
12

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Lucile Capuron, Giuseppe Pagnoni, Daniel F Drake, Bobbi J Woolwine, James R Spivey, Ronald J Crowe, John R Votaw, Mark M Goodman, Andrew H Miller. Arch Gen Psychiatry 2012
206
12

Connecting inflammation with glutamate agonism in suicidality.
Sophie Erhardt, Chai K Lim, Klas R Linderholm, Shorena Janelidze, Daniel Lindqvist, Martin Samuelsson, Kristina Lundberg, Teodor T Postolache, Lil Träskman-Bendz, Gilles J Guillemin,[...]. Neuropsychopharmacology 2013
187
12


Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
Danilo Arnone, Smita Saraykar, Haitham Salem, Antonio L Teixeira, Robert Dantzer, Sudhakar Selvaraj. Neurosci Biobehav Rev 2018
39
30

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
490
11

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
386
11

Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Timothy B Meier, Wayne C Drevets, Brent E Wurfel, Bart N Ford, Harvey M Morris, Teresa A Victor, Jerzy Bodurka, T Kent Teague, Robert Dantzer, Jonathan Savitz. Brain Behav Immun 2016
75
14

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.
M Elizabeth Sublette, Hanga C Galfalvy, Dietmar Fuchs, Manana Lapidus, Michael F Grunebaum, Maria A Oquendo, J John Mann, Teodor T Postolache. Brain Behav Immun 2011
128
11

Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health.
Igor Cervenka, Leandro Z Agudelo, Jorge L Ruas. Science 2017
294
11

The kynurenine pathway in schizophrenia and bipolar disorder.
Sophie Erhardt, Lilly Schwieler, Sophie Imbeault, Göran Engberg. Neuropharmacology 2017
102
11


Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.
Patricia A Zunszain, Christoph Anacker, Annamaria Cattaneo, Shanas Choudhury, Ksenia Musaelyan, Aye Mu Myint, Sandrine Thuret, Jack Price, Carmine M Pariante. Neuropsychopharmacology 2012
232
11

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
Ebrahim Haroon, James R Welle, Bobbi J Woolwine, David R Goldsmith, Wendy Baer, Trusharth Patel, Jennifer C Felger, Andrew H Miller. Neuropsychopharmacology 2020
29
37

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
266
10

Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
Jennifer C Felger, Li Li, Paul J Marvar, Bobbi J Woolwine, David G Harrison, Charles L Raison, Andrew H Miller. Brain Behav Immun 2013
93
10

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Stefania Bonaccorso, Valentina Marino, Antonella Puzella, Massimo Pasquini, Massimo Biondi, Marco Artini, Cristiana Almerighi, Robert Verkerk, Herbert Meltzer, Michael Maes. J Clin Psychopharmacol 2002
302
10

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.
Neil A Harrison, Lena Brydon, Cicely Walker, Marcus A Gray, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2009
416
10

Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
Jonathan Savitz, Robert Dantzer, Brent E Wurfel, Teresa A Victor, Bart N Ford, Jerzy Bodurka, P S F Bellgowan, T Kent Teague, Wayne C Drevets. Psychoneuroendocrinology 2015
68
14

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.
Leandro Z Agudelo, Teresa Femenía, Funda Orhan, Margareta Porsmyr-Palmertz, Michel Goiny, Vicente Martinez-Redondo, Jorge C Correia, Manizheh Izadi, Maria Bhat, Ina Schuppe-Koistinen,[...]. Cell 2014
326
10


Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.
P Zheng, B Zeng, C Zhou, M Liu, Z Fang, X Xu, L Zeng, J Chen, S Fan, X Du,[...]. Mol Psychiatry 2016
615
9

Altered fecal microbiota composition in patients with major depressive disorder.
Haiyin Jiang, Zongxin Ling, Yonghua Zhang, Hongjin Mao, Zhanping Ma, Yan Yin, Weihong Wang, Wenxin Tang, Zhonglin Tan, Jianfei Shi,[...]. Brain Behav Immun 2015
706
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.